Strategic advisory across industrial biotechnology scale-up

Advising founders, executive teams and boards navigating capital-intensive industrial scale-up. Bridging engineering depth, capital discipline and governance clarity to translate complex biosolutions into resilient industrial platforms.

Engagements span executive leadership, scale-up architecture and board-level advisory.

Industrial technology architecture and scale governance

Industrial biotechnology scale-up is shaped by irreversible technical and capital decisions. Early architecture choices determine long-term cost structure, scalability and operational resilience. Advisory engagements focus on aligning process design, plant configuration and governance frameworks with long-term industrial performance and investor expectations.

Scope typically includes:

  • Validation of process scale-up pathways

  • Architecture review from pilot to first commercial plant

  • Cost structure realism and capital intensity alignment

  • Engineering governance and execution sequencing

  • Risk visibility at executive and board level

Executive scale leadership and fractional CTO mandates

During capital inflection phases, organisations require structured technical leadership without premature expansion. Fractional CTO engagements provide executive oversight across engineering, process development and industrial deployment while maintaining disciplined execution and capital clarity.

Mandates may include:

  • Engineering team structuring and capability build-out

  • Technology roadmap alignment under capital constraint

  • Industrial readiness planning

  • Cross-functional coordination between technology, operations and finance

Board and investor advisory on scale risk and capital exposure

As ventures transition from innovation to industrial deployment, board-level oversight of technology scalability and capital exposure becomes decisive. Advisory roles provide independent technical perspective, supporting disciplined capital deployment and governance alignment between executive teams and investors.

Typical focus areas:

  • Independent assessment of scale readiness

  • Technology risk translation for board decision-making

  • Capital sequencing and deployment discipline

  • Industrial cost curve validation

  • Governance alignment across growth phases

Engagement structure

Engagements are structured around defined mandates aligned with scale phase and capital context. Roles may be executive, advisory or board-level, depending on organisational maturity and investment trajectory. The objective is sustained industrial robustness rather than short-term optimisation.

Examples of recent advisory engagements can be found on the portfolio page.

Clear engagement formats:

  • Board and steering committee roles

  • Interim or fractional CTO mandates

  • Fixed-scope strategic architecture reviews

  • Confidential advisory to investors and growth equity

Discuss a strategic advisory mandate

Engagements are selective and aligned with long-term industrial scale ambition.

Scroll to Top